Addex Therapeutics Ltd.

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Revenue from contract with customer $6.0m $2.8m $3.6m $2.9m $1.4m $1.6m $404k $30k $30k
Revenue From Interest $37k $35k $5k $29k $64k $9k
Net Interest Income $1k
$60k +4505.29%
$6k -90.65%
($2k) -143.09%
($3k) -16.85%
Research and development ($2.6m) $4.9m $12.5m $10.4m $12.8m $14.7m $7.0m $854k ($672k) $167k
General and administrative $3.2m $5.0m $5.7m $5.8m $7.3m $5.0m $2.3m $1.8m
General And Administrative Expense $3.3m $2.0m $1.7m $1.9m $1.8m
Operating expenses:
Other Operating Expenses $809k $870k $856k $758k
Total operating costs ($3.7m) ($8.1m) ($17.4m) ($16.1m) ($18.7m) ($22.0m) ($11.9m) ($3.2m) ($3.0m)
Operating loss ($3.2m)
($1.4m) +55.96%
($14.6m) -925.12%
($12.2m) +16.17%
($15.5m) -26.65%
($20.5m) -32.34%
($10.3m) +49.90%
($2.8m) +73.20%
($2.8m) -2.15%
($2.7m) +4.49%
Interest Expense $134k $106k $50k $39k $26k $2k $2k $2k $3k
Interest Expense On Lease Liabilities $23k $19k $24k $23k $20k $2k $3k
Interest Expense Non Operating $28k $4k $4k $2k $3k
Interest Income $37k $35k $217k $29k $64k $27k $0 $0
Net Non Operating Interest Income Expense $1k $60k $6k ($2k) ($3k)
Gain On Sale Of Security ($264k) ($317k) $17k ($13k) $4k
Other Income $500k $659k $71k $266k $237k $23k $34k $6k $143k
Share of net loss of investments accounted for using the equity method ($2.2m) ($4.0m)
Other Income Expense ($264k) ($317k) ($2.2m) ($4.0m) ($4.4m)
Pre-Tax Income ($10.8m) ($2.5m) ($4.9m) ($6.8m) ($7.1m)
Income Tax Expense Continuing Operations $0 $0 $0 $0 $0 $0 $0 $0 $0
Net loss before tax from continuing operations ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) ($4.9m) ($6.8m)
Net loss from continuing operations ($10.8m) ($2.5m) ($4.9m) ($6.8m)
Net Income From Continuing And Discontinued Operation ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) $7.1m ($6.7m) ($7.0m)
Net Income Discontinuous Operations ($10.0m) ($8.1m) $12.0m $114k $114k
Net Income From Continuing Operation Net Minority Interest ($10.8m) ($2.5m) ($4.9m) ($6.8m) ($7.1m)
Basic Earnings (Loss) Per Share ($0.25) ($0.07) ($0.56) ($0.48) ($0.45) ($0.46) ($0.14) $0.07 ($0.06) ($7.20)
Diluted Earnings (Loss) Per Share ($0.25) ($0.07) ($0.56) ($0.48) ($0.45) ($0.46) ($0.14) $0.07 ($0.06) ($7.20)
Basic Average Shares $377k $619k $818k $895k $937k
Diluted Average Shares $685k $619k $818k $895k $937k
Additional Financial Items
Applicable Tax Rate $0 $0 $0 $0 $0 $0
Depreciation Right of Use Assets $324k $359k $320k $292k $281k $74k $16k
Finance Income $37k $35k $217k $29k $64k $27k $0
Profit Loss Before Tax ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) ($4.9m) ($6.8m)
Profit Loss From Operating Activities ($3.2m) ($1.4m) ($14.6m) ($12.2m) ($15.5m) ($20.5m) ($10.3m) ($2.8m) ($2.8m)
General and administration ($1.1m) ($3.2m) ($5.0m) ($5.7m) ($5.8m) ($7.3m) ($5.0m) ($2.3m) ($2.3m)
Finance result ($45k) ($220k) ($176k) ($615k) $154k ($284k) ($275k) $23k ($16k)
Net profit / (loss) from discontinued operations (attributable to equity holders of the Group) ($10.0m) ($8.1m) $12.0m $114k
Net profit / (loss) for the period ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) $7.1m ($6.7m)
From continuing operations ($0) ($0) ($0) ($0)
From discontinued operations ($0) ($0) $0
Depreciation Amortization Depletion Income Statement $9k $12k $193k $8k $16k
Depreciation And Amortization In Income Statement $9k $12k $193k $8k $16k
Depreciation Income Statement $9k $12k $193k $8k $16k
Diluted EPS ($55.20) ($16.80) $8.40 ($7.20) ($7.20)
Diluted NI Availto Com Stockholders ($3.3m) ($1.6m) ($14.8m) ($12.9m) ($15.4m) ($20.8m) ($10.6m) $7.1m ($6.7m) ($7.0m)
Earnings From Equity Interest $0 $0 ($2.2m) ($4.0m) ($4.4m)
Insurance And Claims $1.6m $629k $226k $184k $176k
Normalized EBITDA ($10.2m) ($1.9m) ($4.7m) ($6.8m) ($7.1m)
Normalized Income ($10.5m) ($2.2m) ($4.9m) ($6.8m) ($7.1m)
Other Gand A $1.4m $1.2m $1.2m $1.3m
Reconciled Depreciation $323k $306k $260k $8k $16k
Rent And Landing Fees $38k $47k $36k
Salaries And Wages $253k $239k $243k $389k $508k
Selling General And Administration $3.3m $2.0m $1.7m $1.9m
Tax Effect Of Unusual Items $0 $0 $0 $0 $0 $0 $0 $0 $0
Tax Provision $0 $0 $0 $0 $0 $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0 $0 $0 $0 $0 $0
Employee Benefits Expense $2.2m $4.3m $4.4m $4.7m $7.1m $5.4m $243k
Expense From Share-Based Payment Transactions With Employees $719k $1.3m $901k $947k $3.0m $1.5m $18k
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used $26k $37k $38k $47k $36k
Finance Costs $220k $213k $651k $63k $313k $339k $4k
Postemployment Benefit Expense Defined Benefit Plans $119k $296k $221k $114k $280k $236k ($45k)
Professional Fees Expense $2.3m $2.0m $1.4m $1.4m $1.4m $1.2m $1.2m
Finance expense ($45k) ($220k) ($213k) ($651k) ($63k) ($313k) ($339k) ($4k) ($16k)
Operating Expense $12.0m $3.9m $3.2m $2.8m $2.7m
Rent Expense Supplemental $38k $47k $36k
Net Foreign Exchange Loss $86k $85k $581k
Total Unusual Items ($264k) ($317k) $17k ($13k) $4k
Total Expenses $12.0m $3.9m $3.2m $2.8m $2.7m